Who founded Nuntius Therapeutics?

Nuntius Therapeutics was founded by Benita Nagel, Albert Kwok in 2021.

Who are Nuntius Therapeutics's investors?

Nuntius Therapeutics's investors include Backed, Y Combinator.

Where is Nuntius Therapeutics headquartered?

Nuntius Therapeutics is headquartered in London, GB.

Nuntius Therapeutics

London, GB · Founded 2021 · 2 employees · 2 known investors

Nuntius develops programmable nanocarriers for drug delivery that can target tissues beyond the liver and utilize machine learning to optimize carrier performance. The company serves pharmaceutical and biotech organizations developing targeted therapeutics.

AI & Machine Learning Biotech Deep Tech Healthtech Gene Therapy NanomedicineUnited KingdomEuropePartly Remote

Founders & leadership· Y Combinator alumni (W21)

Nuntius Therapeutics was founded in 2021 by Benita Nagel and Albert Kwok.

Benita NagelinFounder

Albert KwokinFounder

Investors · 2

BackedLondon · $500K – $5M

Y CombinatorSan Francisco · $500K

Competitors · 1

by search overlap

Nuntius4 shared keywordsNuntius builds tools to ensure AI models comply with specified constraints and behave reliably in commercial applications.

Companies competing with Nuntius Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Companies House · registry record

View on Companies House ↗

Registered name: NUNTIUS THERAPEUTICS LIMITED
Company number: 13130725
Status: Active
Company type: Private limited company
Incorporated: 13 Jan 2021
Registered office: Unit 23 The Cobalt Building, Lower Pemberton, Ashford, Kent, TN25 4BF
Nature of business (SIC): 72110 — Research and experimental development on biotechnology
Accounts: last made up to 31 Dec 2024 · next due 30 Sept 2026
Confirmation statement: last made up to 12 Jan 2026 · next due 26 Jan 2027

Current officers · 2

Ngai Ping Albert Kwok — director, appointed 13 Jan 2021
Benita Nagel — director, appointed 13 Jan 2021

Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Nuntius Therapeutics do?: Nuntius develops programmable nanocarriers for drug delivery that can target tissues beyond the liver and utilize machine learning to optimize carrier performance. The company serves pharmaceutical and biotech organizations developing targeted therapeutics.
Who founded Nuntius Therapeutics?: Nuntius Therapeutics was founded by Benita Nagel, Albert Kwok in 2021.
Who are Nuntius Therapeutics's investors?: Nuntius Therapeutics's investors include Backed, Y Combinator.
Where is Nuntius Therapeutics headquartered?: Nuntius Therapeutics is headquartered in London, GB.